BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1498904)

  • 1. Reversible monoamine-A inhibitors in panic disorder.
    Bakish D
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():432A-433A. PubMed ID: 1498904
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible monoamine oxidase-A inhibitors in panic disorder.
    Bakish D; Saxena BM; Bowen R; D'Souza J
    Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
    Bakish D
    J Clin Psychopharmacol; 1994 Feb; 14(1):74-5. PubMed ID: 8151007
    [No Abstract]   [Full Text] [Related]  

  • 4. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
    Tiller JW; Bouwer C; Behnke K
    Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S27-30. PubMed ID: 9466172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A.
    Garcia-Borreguero D; Lauer CJ; Ozdaglar A; Wiedemann K; Holsboer F; Krieg JC
    Pharmacopsychiatry; 1992 Nov; 25(6):261-4. PubMed ID: 1494591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide in social phobia: a pilot open study. GRP Group. Groupe de Recherche en Psychopharmacologie.
    Bisserbe JC; Lépine JP
    Clin Neuropharmacol; 1994; 17 Suppl 1():S88-94. PubMed ID: 7954487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
    Tiller JW; Bouwer C; Behnke K
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB; Dahl AA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.
    van Vliet IM; Westenberg HG; Den Boer JA
    Psychopharmacology (Berl); 1993; 112(4):483-9. PubMed ID: 7871061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
    Priest RG; Gimbrett R; Roberts M; Steinert J
    Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide (Aurorix) in primary major depression.
    Rihmer Z; Barsi J; Vad G; György S; Zalay B; Vég K; Gábor A
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):367-72. PubMed ID: 8208985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moclobemide.
    Ewart S
    Aust Nurses J; 1992; 22(5):32-3. PubMed ID: 1492825
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of moclobemide in clinical use.
    Chen DT
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():428A-429A. PubMed ID: 1498902
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
    Classen W; Laux G
    J Neural Transm Suppl; 1990; 32():185-8. PubMed ID: 2089088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of augmentation with moclobemide on symptoms of schizophrenia.
    Silver H; Aharon N; Hausfater N; Jahjah N
    Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Moclobemide].
    Gleiter C; Volz HP
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of reversible MAO-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():345A-346A. PubMed ID: 1498864
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression: advances in drug treatment.
    Hopkins S
    Nurs Stand; 1993 Nov 24-30; 8(10):36. PubMed ID: 8297750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.